InsidersTradesSigma
Track the Q-linea AB (publ) share price and the full directors' dealings record of the company, a listed equity based in Finland. Shares are listed on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Q-linea AB (publ) has logged 2 public disclosures. Market capitalisation: €311.7m. The latest transaction was disclosed on 11 June 2025 (Purchase). Among the most active insiders: Stuart Gander. All data is accessible without an account.
2
Insider Decl.
n/a
Thresholds
€19,051
2 ops.
Buy Volume
n/a
n/a
Sell Volume
29Σ signal
Fundamental score
Ranked 29,000 of 29,064 companies
3.4
score / 100
Value4
Quality3
FCF yld-51%
Earn yld-55%
EV/EBITDA·
ROE-76%
Gross mgn-15%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 June 2025
Declarations2 total
2,500,000 shares@ €0.00470.0039% mcap61.9% of flowAktieISIN SE0011527845FI:A003P626-1
40,000,000 shares@ €0.00020.0024% mcap38.1% of flowOptionFI:A003O534-1
2 of 2 declarations
关于 Q-linea AB (publ)
Q-linea AB (publ) 是一家瑞典公司，专注于开发感染快速诊断解决方案。该公司在斯德哥尔摩证券交易所 (XSTO) 上市。